Montserrat Bosque

594 total citations
19 papers, 240 citations indexed

About

Montserrat Bosque is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Montserrat Bosque has authored 19 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 6 papers in Immunology and Allergy. Recurrent topics in Montserrat Bosque's work include Asthma and respiratory diseases (9 papers), Allergic Rhinitis and Sensitization (6 papers) and Respiratory and Cough-Related Research (5 papers). Montserrat Bosque is often cited by papers focused on Asthma and respiratory diseases (9 papers), Allergic Rhinitis and Sensitization (6 papers) and Respiratory and Cough-Related Research (5 papers). Montserrat Bosque collaborates with scholars based in Spain, United States and Italy. Montserrat Bosque's co-authors include Òscar Asensio, Christian Domingo, Manel Luján, Rosa M. Mirapeix, Cònsol Serra, Javier de Gracia, Xavier Gallardo, María José Amengual, Miguel Hinojosa and Adalberto Pacheco and has published in prestigious journals such as Cochrane Database of Systematic Reviews, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Montserrat Bosque

19 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Montserrat Bosque Spain 9 173 93 71 65 21 19 240
J PONGRACIC United States 4 85 0.5× 163 1.8× 23 0.3× 98 1.5× 29 1.4× 8 282
Roberta Olcese Italy 11 106 0.6× 177 1.9× 33 0.5× 173 2.7× 17 0.8× 25 304
Dalia El‐Ghoneimy Egypt 8 79 0.5× 59 0.6× 32 0.5× 35 0.5× 22 1.0× 22 234
Hesham Tarraf Egypt 7 169 1.0× 181 1.9× 12 0.2× 45 0.7× 17 0.8× 8 268
Agamemnon Bakakos Greece 7 96 0.6× 134 1.4× 30 0.4× 32 0.5× 20 1.0× 21 182
Mary Noseworthy Canada 4 86 0.5× 133 1.4× 35 0.5× 23 0.4× 15 0.7× 10 171
Janine Beale United Kingdom 4 70 0.4× 194 2.1× 63 0.9× 78 1.2× 63 3.0× 7 339
Miguel García González Spain 6 53 0.3× 21 0.2× 28 0.4× 22 0.3× 20 1.0× 20 160
Kugathasan Mutalithas United Kingdom 6 279 1.6× 295 3.2× 20 0.3× 88 1.4× 22 1.0× 9 426
Robert W. Sugerman United States 5 71 0.4× 100 1.1× 79 1.1× 197 3.0× 7 0.3× 14 269

Countries citing papers authored by Montserrat Bosque

Since Specialization
Citations

This map shows the geographic impact of Montserrat Bosque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Montserrat Bosque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Montserrat Bosque more than expected).

Fields of papers citing papers by Montserrat Bosque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Montserrat Bosque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Montserrat Bosque. The network helps show where Montserrat Bosque may publish in the future.

Co-authorship network of co-authors of Montserrat Bosque

This figure shows the co-authorship network connecting the top 25 collaborators of Montserrat Bosque. A scholar is included among the top collaborators of Montserrat Bosque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Montserrat Bosque. Montserrat Bosque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
García-Núñez, Marian, Miguel García González, Xavier Pomares, et al.. (2020). The Respiratory Microbiome in Cystic Fibrosis: Compartment Patterns and Clinical Relationships in Early Stage Disease. Frontiers in Microbiology. 11. 1463–1463. 13 indexed citations
2.
Fierro, Vincenzo, Rocco Luigi Valluzzi, Claudia Banzato, et al.. (2020). A well‐tolerated new amino acid–based formula for cow's milk allergy. Immunity Inflammation and Disease. 8(2). 140–149. 4 indexed citations
3.
Tortajada‐Girbés, Miguel, Montserrat Bosque, María Dolores Ibáñez, et al.. (2018). Efficacy and effectiveness of omalizumab in the treatment of childhood asthma. Expert Review of Respiratory Medicine. 12(9). 745–754. 8 indexed citations
4.
Trujillo, Juan, et al.. (2014). PD42 ‐ Is rituximab a trigger for persistent hypogammaglobulinemia in idiopathic nephrotic syndrome?. Clinical and Translational Allergy. 4(S1). 4 indexed citations
5.
Bosque, Montserrat, Laura Valdesoiro Navarrete, H. Larramona, et al.. (2013). Induced Sputum Versus Exhaled Nitric Oxide for the Evaluation of Airway Inflammation in Allergic Pediatric Asthma Patients Treated With Omalizumab. CHEST Journal. 144(4). 761A–761A. 2 indexed citations
6.
Luján, Manel, Xavier Gallardo, María José Amengual, et al.. (2013). Prevalence of Bronchiectasis in Asthma according to Oral Steroid Requirement: Influence of Immunoglobulin Levels. BioMed Research International. 2013. 1–7. 32 indexed citations
7.
Cruz, María Jesús, et al.. (2013). Observational study of the safety of a cluster schedule for subcutaneous immunotherapy in a pediatric population.. PubMed. 23(1). 63–5. 6 indexed citations
8.
Martín‐Muñoz, M.F., Fernando Pineda, Miguel Pérez Fontán, et al.. (2012). Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment. Allergologia et Immunopathologia. 41(1). 4–10. 6 indexed citations
9.
Domingo, Christian, Adalberto Pacheco, Miguel Hinojosa, & Montserrat Bosque. (2007). The Relevance of IgE in the Pathogenesis of Allergy: The Effect of an Anti-IgE Drug in Asthma and Other Diseases. Recent Patents on Inflammation & Allergy Drug Discovery. 1(2). 151–164. 14 indexed citations
10.
Sterba, Gary, et al.. (2006). Macrophage Activation Syndrome (MAS) as a Debut of Systemic Lupus Erythematosus (SLE) in a Child.. Journal of Allergy and Clinical Immunology. 117(2). S210–S210. 4 indexed citations
11.
Navarrete, Laura Valdesoiro, et al.. (2004). Rinitis alérgica e hiperreactividad bronquial. Allergologia et Immunopathologia. 32(6). 340–343. 10 indexed citations
12.
Domingo, Christian, et al.. (2004). Shrinking Lung Syndrome: A Pulmonary Manifestation of Systemic Lupus Erythematosus Diurnal Findings and Nocturnal Events. 3 indexed citations
13.
Tella, R., Joan Bartra, Montserrat Olona, et al.. (2003). Effects of specific immunotherapy on the development of new sensitisations in monosensitised patients. Allergologia et Immunopathologia. 31(4). 221–225. 9 indexed citations
14.
Luján, Manel, et al.. (2002). Late-Onset Congenital Cystic Adenomatoid Malformation of the Lung. Respiration. 69(2). 148–154. 64 indexed citations
15.
Bosque, Montserrat, et al.. (2002). Inmunoterapia con un extracto de ácaros en niños menores de cinco años. Allergologia et Immunopathologia. 30(1). 20–24. 4 indexed citations
16.
Gratacós, Jordi, et al.. (2001). FRI0134 Shrinking lung syndrome as a clinical manifestation of patients with sle: 5 cases report. Annals of the Rheumatic Diseases. 60. A70–A70. 1 indexed citations
17.
Asensio, Òscar, et al.. (2000). Home intravenous antibiotics for cystic fibrosis. Cochrane Database of Systematic Reviews. CD001917–CD001917. 32 indexed citations
18.
Asensio, Òscar, et al.. (1996). [Multicenter drug surveillance of sublingual immunotherapy in allergic patients].. PubMed. 23(4). 153–9. 14 indexed citations
19.
Just, Jeanette J., Jordi Casabona, Clàudia Fortuny, et al.. (1996). MHC class II alleles associated with clinical and immunological manifestations of HIV‐1 infection among children in Catalonia, Spain. Tissue Antigens. 47(4). 313–318. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J PONGRACIC Breakdown of academic impact, for papers by Roberta Olcese Breakdown of academic impact, for papers by Dalia El‐Ghoneimy Breakdown of academic impact, for papers by Hesham Tarraf Breakdown of academic impact, for papers by Agamemnon Bakakos Breakdown of academic impact, for papers by Mary Noseworthy Breakdown of academic impact, for papers by Janine Beale Breakdown of academic impact, for papers by Miguel García González Breakdown of academic impact, for papers by Kugathasan Mutalithas Breakdown of academic impact, for papers by Robert W. Sugerman
Rankless by CCL
2026